JD HEALTH
06618
JD-SW
09618
BEKE-W
02423
TRIP.COM-S
09961
NTES-S
09999
(Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
---|---|---|---|---|---|
Turnover | 38.04%72.53B | 40.71%120.62B | --52.54B | 31.08%85.72B | --65.4B |
Operating income | 38.04%72.53B | 40.71%120.62B | 52.54B | 31.08%85.72B | 65.4B |
Cost of sales | -6.78%-30.04B | -47.93%-60.52B | ---28.14B | -72.43%-40.91B | ---23.73B |
Operating expenses | -6.78%-30.04B | -47.93%-60.52B | -28.14B | -72.43%-40.91B | -23.73B |
Gross profit | 74.09%42.48B | 34.12%60.1B | 24.4B | 7.54%44.81B | 41.67B |
Selling expenses | 41.81%-6.07B | 61.88%-18.05B | ---10.43B | -208.95%-47.35B | ---15.32B |
Administrative expenses | 11.03%-3.68B | -98.89%-9.98B | ---4.14B | 39.50%-5.02B | ---8.29B |
Research and development expenses | -22.78%-5.72B | -53.63%-10.61B | ---4.66B | -44.14%-6.9B | ---4.79B |
Impairment and provision | 62.91%-45.45M | -912.06%-297M | ---122.53M | -119.83%-29.35M | --147.99M |
-Other impairment is provision | 62.91%-45.45M | -912.06%-297M | ---122.53M | -119.83%-29.35M | --147.99M |
Special items of operating profit | -162.40%-2.07B | -84.73%2.9B | ---789.06M | 8,388.28%18.98B | ---229.06M |
Operating profit | 482.80%24.9B | 434.64%24.07B | 4.27B | -65.85%4.5B | 13.18B |
Financing income | 5,445.27%543.67M | -33.86%91.02M | ---10.17M | 198.23%137.62M | ---140.1M |
Share of profits of associates | 17.51%-1.03B | -103.82%-3.11B | ---1.25B | 27.14%-1.53B | ---2.09B |
Earning before tax | 709.25%24.42B | 576.03%21.05B | 3.02B | -71.56%3.11B | 10.95B |
Tax | -121.80%-2.5B | -211.12%-2.98B | ---1.13B | 65.08%-958M | ---2.74B |
After-tax profit from continuing operations | 1,058.59%21.92B | 738.17%18.07B | 1.89B | -73.72%2.16B | 8.2B |
Earning after tax | 1,058.59%21.92B | 738.17%18.07B | 1.89B | -73.72%2.16B | 8.2B |
Minority profit | 29.77%688.88M | -25.14%1.11B | --530.85M | 18.79%1.49B | --1.25B |
Profit attributable to shareholders | 1,459.75%21.23B | 2,442.06%16.96B | 1.36B | -90.40%667.07M | 6.95B |
Basic earnings per share | 900.00%0.8 | 2,025.00%0.85 | 0.08 | -91.30%0.04 | 0.46 |
Diluted earnings per share | 900.00%0.8 | 2,025.00%0.85 | 0.08 | -91.30%0.04 | 0.46 |
Currency Unit | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.